Completed
Phase 2
Age: 34Years - 51Years
All Genders
ID00000233
Alternate Day Buprenorphine Administration, Phase X
Led by National Institute on Drug Abuse (NIDA) · Updated on 2005-08-17
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
N
National Institute on Drug Abuse (NIDA)
Lead Sponsor
U
University of Vermont
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to determine how subjects will make changes in the amount of medication received when given a monetary alternative to buprenorphine.
CONDITIONS
Brief Title
Alternate Day Buprenorphine Administration, Phase X - 15
Who Can Participate
Age: 34Years - 51Years
All Genders
Eligibility Criteria
Please contact site for information.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here